PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
| 2024-04-16 5:57:27 PM | Chg. -0.40 | Volume | Bid5:57:34 PM | Ask5:57:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 22.40EUR | -1.75% | 100 Turnover: 2,240 |
22.40Bid Size: 120 | 22.60Ask Size: 50 | 273.6 mill.EUR | 1.97% | 25.62 |
Assets
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
|---|---|---|---|---|---|
| Property and Equipment | .4000 | .4000 | |||
| Intangible Assets | 1.8000 | 82.2000 | |||
| Long-Term Investments | .0600 | 0.0000 | |||
| Fixed Assets | - | - | |||
| Inventories | 3 | 4.2000 | |||
| Accounts Receivable | - | - | |||
| Cash and Cash Equivalents | 8 | 20.8000 | |||
| Current Assets | 22.4000 | 32.5000 | |||
| Total Assets | 24.9000 | 115.3000 | |||
Liabilities
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
|---|---|---|---|---|---|
| Accounts Payable | 9.8000 | 4.5000 | |||
| Long-term debt | - | - | |||
| Liabilities to Banks | 1.2000 | 85.7000 | |||
| Provisions | 1 | 1.2000 | |||
| Liabilities | 13.4000 | 93 | |||
| Share Capital | - | - | |||
| Total Equity | 11.5070 | 22.1970 | |||
| Minority Interests | - | - | |||
| Total liabilities equity | 24.9000 | 115.3000 | |||
Income Statement
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
|---|---|---|---|---|---|
| Revenues | 63.2000 | 65.3000 | |||
| Depreciation (total) | .5000 | 3.6000 | |||
| Operating Result | 14.2000 | 14.9000 | |||
| Interest Income | -.0900 | -.7000 | |||
| Income Before Taxes | 14.1000 | 14.2000 | |||
| Income Taxes | 3.5000 | 3.5000 | |||
| Minority Interests Profit | - | - | |||
| Net Income | 10.6000 | 10.7000 | |||
Per Share
Cash Flow
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 15.5000 | 12.2000 | |||
| Cash Flow from Investing Activities | -.9000 | -83.5000 | |||
| Cash Flow from Financing | -95 | 84 | |||
| Decrease / Increase in Cash | -80.5000 | 12.8000 | |||
| Employees | 60 | 75 | |||
